This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wolden, S. L. Articles by Leibel, S. A. Search for Related Content PubMed PubMed Citation Articles by Wolden, S. L. Articles by Leibel, S. A. Social Bookmarking                            What's this?

Patterns of Failure Using a Conformal Radiation Therapy Tumor Bed Boost for Medulloblastoma

From the Departments of Radiation Oncology, Pediatrics, and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.

Address reprint requests to Suzanne L. Wolden, MD, Department of Radiation Oncology, 1275 York Ave, Box 22, New York, NY 10021; email: woldens{at}mskcc.org.

Purpose: To assess the patterns of failure for patients with medulloblastoma receiving a conformal tumor bed boost rather than a boost to the entire posterior fossa.

Patients and Methods: From 1994 to 2002, 32 consecutive patients with newly diagnosed medulloblastoma treated at Memorial Sloan-Kettering Cancer Center (New York, NY) received a conformal boost to the tumor bed in conjunction with craniospinal radiation therapy. Twenty-eight patients also received chemotherapy. The median age was 9 years (range, 3 to 34 years), and the male to female ratio was 3:1. Twenty-seven patients had standard-risk disease, and five patients had high-risk disease. Craniospinal doses ranged from 23.4 to 39.6 Gy, and total tumor bed doses ranged from 54 to 59.4 Gy.

Results: With a median follow-up of 56 months, six patients have relapsed; five relapsed outside of the posterior fossa, and one failed within the posterior fossa, outside of the high-dose boost volume. Five-year actuarial disease-free and overall survival rates were 84% and 85%, respectively. Freedom from posterior fossa failure was 100% and 86% at 5 and 10 years, respectively. Freedom from distant failure was 84% at 5 years, with a trend for improvement when full-dose craniospinal radiation (36 to 39.6 Gy) was used compared with a reduced dose (23.4 Gy) of radiation (100% v 63%, respectively; P = .06). No other predictive variables were identified.

Conclusion: Conformal treatment to the tumor bed allows for significant sparing of critical structures. The posterior fossa failure rate in this series is similar to that reported when the entire posterior fossa is treated. This approach should be investigated further in a phase III trial.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Carrie, J. Grill, D. Figarella-Branger, V. Bernier, L. Padovani, J. L. Habrand, M. Benhassel, M. Mege, M. Mahe, P. Quetin, et al. Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98 J. Clin. Oncol., April 10, 2009; 27(11): 1879 - 1883. [Abstract] [Full Text] [PDF]

				P. P. Connell and S. Hellman Advances in Radiotherapy and Implications for the Next Century: A Historical Perspective Cancer Res., January 15, 2009; 69(2): 383 - 392. [Full Text] [PDF]

				B Pizer and S Clifford Medulloblastoma: new insights into biology and treatment Arch. Dis. Child. Ed. Pract., October 1, 2008; 93(5): 137 - 144. [Full Text] [PDF]

				S. L. Palmer, W. E. Reddick, and A. Gajjar Understanding the Cognitive Impact on Children Who are Treated for Medulloblastoma J. Pediatr. Psychol., October 1, 2007; 32(9): 1040 - 1049. [Abstract] [Full Text] [PDF]

				G Bauman, S Yartsev, T Coad, B Fisher, and T Kron Helical tomotherapy for craniospinal radiation Br. J. Radiol., June 1, 2005; 78(930): 548 - 552. [Abstract] [Full Text] [PDF]

				D. G. Kirsch and N. J. Tarbell Conformal Radiation Therapy for Childhood CNS Tumors Oncologist, July 1, 2004; 9(4): 442 - 450. [Abstract] [Full Text] [PDF]